Paper34952829
Epigenetic basis and targeting of cancer metastasis.
Banerjee R and 4 others. Trends Cancer, 2022. Cited by 38 papers, by iCite.
Cite this record
ConductScience Library. Epigenetic basis and targeting of cancer metastasis. Papers, record 34952829. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34952829
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Epigenomics | Major topic |
| Neoplasms | Major topic |
| Epigenesis, Genetic | |
| Humans |
Source PubMed
Cited by31
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 38 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42966745 | KDM1A promotes colorectal cancer progression by regulating NRP2 and VEGFA-related signaling. | Oncogene | 2026 | https://conductscience.org/library/papers/42966745 | PubMed |
| 42373805 | DNA methylation-mediated silencing of STAT5A drives breast cancer metastasis via dual regulation of EMT and immunosuppressive microenvironment. | Oncogene | 2026 | https://conductscience.org/library/papers/42373805 | PubMed |
| 41971440 | The symbiotic axis between the acidic tumor microenvironment and cancer stem cells: a driver of malignancy and therapeutic resistance. | Front Oncol | 2026 | https://conductscience.org/library/papers/41971440 | PubMed |
| 41898551 | Epigenetic Deregulation of Transposable Elements Links Developmental Processes and Tumorigenesis. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41898551 | PubMed |
| 41869309 | ADAMTS9-AS2 acts as an epigenetic brake to constrain DNMT3B-mediated CADM2 silencing in esophageal squamous cell carcinoma metastasis. | Front Immunol | 2026 | https://conductscience.org/library/papers/41869309 | PubMed |
| 41083431 | The noncanonical function of liver-type phosphofructokinase potentiates the efficacy of HDAC inhibitors in cancer. | Signal Transduct Target Ther | 2025 | https://conductscience.org/library/papers/41083431 | PubMed |
| 40691387 | Epigenetic dysregulation in cancer: mechanisms, diagnostic biomarkers and therapeutic strategies. | Med Oncol | 2025 | https://conductscience.org/library/papers/40691387 | PubMed |
| 40675967 | Targeting epigenetic regulators as a promising avenue to overcome cancer therapy resistance. | Signal Transduct Target Ther | 2025 | https://conductscience.org/library/papers/40675967 | PubMed |
| 40473600 | SWI/SNF ATPase silenced HLF potentiates lung metastasis in solid cancers. | Nat Commun | 2025 | https://conductscience.org/library/papers/40473600 | PubMed |
| 40287757 | YEATS2: a novel cancer epigenetic reader and potential therapeutic target. | Cancer Cell Int | 2025 | https://conductscience.org/library/papers/40287757 | PubMed |
| 39904827 | EZH2-Mediated PHF10 Suppression Amplifies HMGB1/NF-κB Axis That Confers Chemotherapy Resistance in Cholangiocarcinoma. | J Cell Mol Med | 2025 | https://conductscience.org/library/papers/39904827 | PubMed |
| 39725831 | Pan-cancer and multiomics: advanced strategies for diagnosis, prognosis, and therapy in the complex genetic and molecular universe of cancer. | Clin Transl Oncol | 2025 | https://conductscience.org/library/papers/39725831 | PubMed |
| 39581913 | Vaping and tumor metastasis: current insights and progress. | Cancer Metastasis Rev | 2024 | https://conductscience.org/library/papers/39581913 | PubMed |
| 39391208 | From microscopes to molecules: The evolution of prostate cancer diagnostics. | Cytojournal | 2024 | https://conductscience.org/library/papers/39391208 | PubMed |
| 39095874 | Cancer, metastasis, and the epigenome. | Mol Cancer | 2024 | https://conductscience.org/library/papers/39095874 | PubMed |
| 38800486 | The effect of epigenetic aging on neurodegenerative diseases: a Mendelian randomization study. | Front Endocrinol (Lausanne) | 2024 | https://conductscience.org/library/papers/38800486 | PubMed |
| 38473261 | Targeted DNA Methylation Editing Using an All-in-One System Establishes Paradoxical Activation of EBF3. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38473261 | PubMed |
| 38357830 | Integrated Multiomics Reveals Silencing of has_circ_0006646 Promotes TRIM21-Mediated NCL Ubiquitination to Inhibit Hepatocellular Carcinoma Metastasis. | Adv Sci (Weinh) | 2024 | https://conductscience.org/library/papers/38357830 | PubMed |
| 38255946 | Exploring Potential Epigenetic Biomarkers for Colorectal Cancer Metastasis. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38255946 | PubMed |
| 37985455 | Application of deep learning in cancer epigenetics through DNA methylation analysis. | Brief Bioinform | 2023 | https://conductscience.org/library/papers/37985455 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34952829
GET https://conductscience.org/api/papers/v1/34952829/cited_by?page=2